Related Experiment Video

Updated: Aug 23, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

Pertussis. Presentation, investigation and management

Alexis Frydenberg1, Mike Starr

  • 1Paediatric Infectious Diseases Unit, Department of General Medicine, Royal Children's Hospital, Melbourne, Victoria.

Australian Family Physician
|July 2, 2004
PubMed

Insights

Pertussis, or whooping cough, is a serious infectious disease. Infants are highly vulnerable until vaccinated, highlighting the importance of timely immunization schedules and prompt diagnosis.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Pertussis (whooping cough) is a highly contagious disease.
  • It leads to substantial illness and death.
  • Vaccination is key to prevention.

Purpose of the Study:

  • To outline the clinical presentations of pertussis.
  • To detail diagnostic investigations for pertussis.
  • To describe the management of pertussis cases and their contacts.

Main Methods:

  • Clinical case reviews.
  • Diagnostic testing including immunofluorescence.
  • Review of vaccination schedules and management protocols.

Main Results:

  • Infants are at high risk due to lack of maternal antibody protection until primary vaccination series completion (2, 4, 6 months).
  • Clinical diagnosis is primary; immunofluorescence confirms.
  • Recent Australian vaccination schedule changes include DTPa dose adjustments and a new adolescent booster.

Conclusions:

  • Infants require vaccination for protection against pertussis.
  • Early diagnosis and management are crucial.
  • Vaccination schedule updates aim to improve population immunity.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...